Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology
Clinical trial NCT03842163 · COMPLETED
Trial details
- NCT number
- NCT03842163
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-09
- Primary completion
- 2022-06-08
- Enrollment
- 812
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.